The Portuguese generic medicines market: What's next?
AM Nunes, DC Ferreira, A de Matos, RM Julião - Health Policy, 2020 - Elsevier
Brand-name medicines have dominated the Portuguese market for several decades with
unquestionable exclusivity. This resulted particularly from the absence of a requirement of …
unquestionable exclusivity. This resulted particularly from the absence of a requirement of …
Variations in patients' perceptions and use of generic drugs: results of a national survey
ABSTRACT BACKGROUND Over 84% of all prescriptions in the US are filled as generic
drugs, though in prior surveys, patients reported concerns about their quality. OBJECTIVE …
drugs, though in prior surveys, patients reported concerns about their quality. OBJECTIVE …
Regulation of pharmaceutical prices: evidence from a reference price reform in Denmark
Reference price systems for prescription drugs constitute widely adopted cost containment
tools. Under these regimes, patients co-pay a fraction of the difference between a drug's …
tools. Under these regimes, patients co-pay a fraction of the difference between a drug's …
The unified medical prescription as a tool to promote generic prescription: a cross-sectional study addressing physicians' perception in Lebanon
G Hatem, E Lahoud, L Halwani… - Journal of Generic …, 2022 - journals.sagepub.com
INTRODUCTION: The unified medical prescription was implemented as a policy to decrease
the overall health expenditures and increase the use of generic drugs. The main objective of …
the overall health expenditures and increase the use of generic drugs. The main objective of …
Physicians' perceptions towards brand medicine and its effect on prescribing: a narrative review
MA Murshid, Z Mohaidin - Journal of Generic Medicines, 2017 - journals.sagepub.com
Objective The purpose of this paper is to examine existing literature on physicians'
perceptions towards brand medicines, to examine the extent to which brands influence drug …
perceptions towards brand medicines, to examine the extent to which brands influence drug …
[HTML][HTML] The effect of inertia on brand-name versus generic drug choices
Consumers' tendency to repurchase products is called inertia. This study investigates inertia
in brand-name and generic drug choices, which is manifested by the slow and limited …
in brand-name and generic drug choices, which is manifested by the slow and limited …
[HTML][HTML] Providing a model for brand strength in banking industry using yazd city banks
A Baniyani, MH Ahmadi, M Motamedi… - Asia Pacific management …, 2021 - Elsevier
Brand is one of the most valuable assets of the organization invested and developed over
time, creating competitive power for organizations, and allowing organizations to create long …
time, creating competitive power for organizations, and allowing organizations to create long …
Generic drugs in times of economic crisis: Are there changes in consumer purchase intention?
VL Ferreira, CRP da Veiga, C Kudlawicz-Franco… - Journal of Retailing and …, 2017 - Elsevier
This research aims to investigate the moderating role of an economic crisis in the consumer
purchase intention toward generic drugs (GDs), and it uses a quantitative questionnaire …
purchase intention toward generic drugs (GDs), and it uses a quantitative questionnaire …
[HTML][HTML] Enhancing Taiwan's healthcare sustainability: A Delphi study on national medicines policy reforms
CF Huang, KL Chen, FJ Lin, CC Wang, CS Gau… - Journal of the Formosan …, 2024 - Elsevier
Abstract Background/purpose The National Medicines Policy (NMP) is crucial as it sets the
framework for ensuring access to affordable, high-quality medicines and promoting their …
framework for ensuring access to affordable, high-quality medicines and promoting their …
[图书][B] Extra costs of integrity: Pharmacy markups and generic substitution in Finland
O Izhak - 2019 - econstor.eu
I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on
the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data …
the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data …